SANUWAVE Health, Inc. SNWV
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 43.90M | 44.22M | 43.93M | 41.16M | 39.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.90M | 44.22M | 43.93M | 41.16M | 39.07M |
| Cost of Revenue | 10.42M | 10.31M | 10.08M | 8.98M | 8.74M |
| Gross Profit | 33.48M | 33.91M | 33.85M | 32.19M | 30.33M |
| SG&A Expenses | 36.18M | 35.39M | 34.12M | 31.16M | 29.02M |
| Depreciation & Amortization | 1.01M | 934.00K | 880.00K | 809.00K | 793.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.14M | 52.73M | 50.72M | 44.51M | 41.93M |
| Operating Income | 2.86M | 4.58M | 6.30M | 6.98M | 7.47M |
| Income Before Tax | 14.41M | 15.63M | 10.95M | -9.67M | -40.66M |
| Income Tax Expenses | 92.00K | 86.00K | 86.00K | 27.00K | 27.00K |
| Earnings from Continuing Operations | 14.31 | 15.55 | 10.87 | -9.70 | -40.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.31M | 15.55M | 10.87M | -9.70M | -40.68M |
| EBIT | 2.86M | 4.58M | 6.30M | 6.98M | 7.47M |
| EBITDA | 4.39M | 5.98M | 7.62M | 8.05M | 8.47M |
| EPS Basic | 1.67 | 1.81 | 1.27 | -1.17 | -8.85 |
| Normalized Basic EPS | 1.30 | 1.39 | 1.05 | -2.54 | -7.03 |
| EPS Diluted | 0.24 | 0.27 | -0.28 | -2.02 | -8.97 |
| Normalized Diluted EPS | 1.25 | 1.33 | 0.99 | -2.57 | -7.03 |
| Average Basic Shares Outstanding | 34.34M | 34.30M | 34.25M | 34.09M | 28.71M |
| Average Diluted Shares Outstanding | 35.13M | 35.70M | 35.65M | 35.27M | 29.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |